Alzheimer’s Disease

Buntanetap mechanism of action

Buntanetap shows promise for the treatment of Alzheimer’s disease and Parkinson’s disease

MBI associated with decreased connectivity in networks linked with Alzheimer’s disease

What drives network hyperexcitability in Alzheimer’s disease?

Anti-HMGB1 agents for the treatment of Alzheimer’s disease

New diagnostic criteria for apathy in neurocognitive disorders

What is the relationship between COVID-19 and Alzheimer’s disease?

What is the future of modifiable dementia risk factors research?

Is there a genetic basis for the rate of progression of Alzheimer’s disease?

Impact of Alzheimer’s disease treatments on apathy

Modifiable dementia risk factors associated with higher CSF tau and poorer cognition in middle age

The prodromal phases of Alzheimer’s disease

Improving diet to reduce risk of cogntive decline and dementia

Role of ancestry in the predictivity of genetic data

Early predictive value of plasma biomarkers for amyloid positivity

CSF tau as a biomarker of therapeutic effect